In recent years, chimeric antigen receptor (CAR) T-cell therapy has emerged as one of the most promising immunotherapy for the treatment of cancer. This therapy
Cancer immunotherapy has progressed tremendously in recent years, with the emergence of innovative approaches like chimeric antigen receptor (CAR) T-cell therapy and T-cell receptor (TCR)
To support preclinical in-vivo research and development, GemPharmatech has developed a comprehensive platform for gene-edited cell line customization, reporter gene cell line
Our dedication to advancing preclinical research goes beyond providing innovative mouse models; we are also committed to supporting our customers by offering preclinical efficacy services.
Contact our Customer Care, Sales & Scientific Assistance
Consult and asked questions about our products & services
Documentation of Technical & Safety Data Sheet, Guides and more...